TERRASCEND CORP (TSND.CA) Stock Fundamental Analysis

TSX:TSND • CA88105E1088

0.85 CAD
-0.01 (-1.16%)
Last: Feb 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TSND. TSND was compared to 33 industry peers in the Pharmaceuticals industry. TSND has a bad profitability rating. Also its financial health evaluation is rather negative. TSND is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • TSND had negative earnings in the past year.
  • In the past year TSND had a positive cash flow from operations.
  • In the past 5 years TSND reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: TSND reported negative operating cash flow in multiple years.
TSND.CA Yearly Net Income VS EBIT VS OCF VS FCFTSND.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -21.71%, TSND is doing worse than 63.64% of the companies in the same industry.
  • With a Return On Equity value of -128.44%, TSND is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
  • TSND has a Return On Invested Capital of 5.70%. This is in the better half of the industry: TSND outperforms 78.79% of its industry peers.
Industry RankSector Rank
ROA -21.71%
ROE -128.44%
ROIC 5.7%
ROA(3y)-24.86%
ROA(5y)-21.32%
ROE(3y)-62.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TSND.CA Yearly ROA, ROE, ROICTSND.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800

1.3 Margins

  • The Operating Margin of TSND (13.76%) is better than 78.79% of its industry peers.
  • In the last couple of years the Operating Margin of TSND has declined.
  • Looking at the Gross Margin, with a value of 51.29%, TSND is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
  • In the last couple of years the Gross Margin of TSND has grown nicely.
Industry RankSector Rank
OM 13.76%
PM (TTM) N/A
GM 51.29%
OM growth 3Y-5.82%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.82%
GM growth 5Y37.79%
TSND.CA Yearly Profit, Operating, Gross MarginsTSND.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TSND is destroying value.
  • The number of shares outstanding for TSND has been increased compared to 1 year ago.
  • Compared to 5 years ago, TSND has more shares outstanding
  • Compared to 1 year ago, TSND has a worse debt to assets ratio.
TSND.CA Yearly Shares OutstandingTSND.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
TSND.CA Yearly Total Debt VS Total AssetsTSND.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • TSND has an Altman-Z score of -1.07. This is a bad value and indicates that TSND is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of TSND (-1.07) is comparable to the rest of the industry.
  • TSND has a debt to FCF ratio of 22.68. This is a negative value and a sign of low solvency as TSND would need 22.68 years to pay back of all of its debts.
  • TSND has a Debt to FCF ratio of 22.68. This is in the better half of the industry: TSND outperforms 63.64% of its industry peers.
  • A Debt/Equity ratio of 2.26 is on the high side and indicates that TSND has dependencies on debt financing.
  • TSND has a worse Debt to Equity ratio (2.26) than 78.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.26
Debt/FCF 22.68
Altman-Z -1.07
ROIC/WACC0.57
WACC10.02%
TSND.CA Yearly LT Debt VS Equity VS FCFTSND.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.56 indicates that TSND should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.56, TSND is in line with its industry, outperforming 48.48% of the companies in the same industry.
  • A Quick Ratio of 1.12 indicates that TSND should not have too much problems paying its short term obligations.
  • TSND has a Quick ratio (1.12) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.12
TSND.CA Yearly Current Assets VS Current LiabilitesTSND.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • TSND shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.00%.
  • TSND shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.62%.
  • Measured over the past years, TSND shows a very strong growth in Revenue. The Revenue has been growing by 36.80% on average per year.
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)-13.62%
Revenue growth 3Y13.38%
Revenue growth 5Y36.8%
Sales Q2Q%-12.22%

3.2 Future

  • TSND is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.08% yearly.
  • Based on estimates for the next years, TSND will show a small growth in Revenue. The Revenue will grow by 0.38% on average per year.
EPS Next Y24.44%
EPS Next 2Y33.17%
EPS Next 3Y22.74%
EPS Next 5Y13.08%
Revenue Next Year-14.04%
Revenue Next 2Y-6.56%
Revenue Next 3Y-2.86%
Revenue Next 5Y0.38%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TSND.CA Yearly Revenue VS EstimatesTSND.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
TSND.CA Yearly EPS VS EstimatesTSND.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • TSND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TSND. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TSND.CA Price Earnings VS Forward Price EarningsTSND.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • 78.79% of the companies in the same industry are more expensive than TSND, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, TSND is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.49
EV/EBITDA 7.5
TSND.CA Per share dataTSND.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

  • TSND's earnings are expected to grow with 22.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.17%
EPS Next 3Y22.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TSND does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TERRASCEND CORP

TSX:TSND (2/11/2026, 7:00:00 PM)

0.85

-0.01 (-1.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)03-04
Inst Owners38.67%
Inst Owner ChangeN/A
Ins Owners5.75%
Ins Owner ChangeN/A
Market Cap313.01M
Revenue(TTM)275.46M
Net Income(TTM)-120.56M
Analysts82.22
Price Target1.79 (110.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-481.28%
Min EPS beat(2)-614.39%
Max EPS beat(2)-348.18%
EPS beat(4)0
Avg EPS beat(4)-310.68%
Min EPS beat(4)-614.39%
Max EPS beat(4)-20.66%
EPS beat(8)0
Avg EPS beat(8)-308.43%
EPS beat(12)1
Avg EPS beat(12)-207.87%
EPS beat(16)2
Avg EPS beat(16)-327.17%
Revenue beat(2)0
Avg Revenue beat(2)-4.75%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-3.35%
Revenue beat(4)0
Avg Revenue beat(4)-3.84%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)-2.6%
Revenue beat(8)0
Avg Revenue beat(8)-4.34%
Revenue beat(12)2
Avg Revenue beat(12)-3.04%
Revenue beat(16)2
Avg Revenue beat(16)-5.41%
PT rev (1m)0%
PT rev (3m)-8.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-14.29%
EPS NY rev (3m)-70.21%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.84
P/FCF 23.49
P/OCF 9.92
P/B 2.46
P/tB N/A
EV/EBITDA 7.5
EPS(TTM)-0.54
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.04
FCFY4.26%
OCF(TTM)0.09
OCFY10.08%
SpS1.01
BVpS0.35
TBVpS-0.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.71%
ROE -128.44%
ROCE 7.91%
ROIC 5.7%
ROICexc 6.18%
ROICexgc 17.05%
OM 13.76%
PM (TTM) N/A
GM 51.29%
FCFM 3.57%
ROA(3y)-24.86%
ROA(5y)-21.32%
ROE(3y)-62.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-2.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y1.66%
ROICexc growth 5YN/A
OM growth 3Y-5.82%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.82%
GM growth 5Y37.79%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 2.26
Debt/FCF 22.68
Debt/EBITDA 3.83
Cap/Depr 77.06%
Cap/Sales 4.88%
Interest Coverage 1.43
Cash Conversion 42.03%
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.12
Altman-Z -1.07
F-Score6
WACC10.02%
ROIC/WACC0.57
Cap/Depr(3y)90.87%
Cap/Depr(5y)192.32%
Cap/Sales(3y)7.77%
Cap/Sales(5y)14.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
EPS Next Y24.44%
EPS Next 2Y33.17%
EPS Next 3Y22.74%
EPS Next 5Y13.08%
Revenue 1Y (TTM)-13.62%
Revenue growth 3Y13.38%
Revenue growth 5Y36.8%
Sales Q2Q%-12.22%
Revenue Next Year-14.04%
Revenue Next 2Y-6.56%
Revenue Next 3Y-2.86%
Revenue Next 5Y0.38%
EBIT growth 1Y14.74%
EBIT growth 3Y6.79%
EBIT growth 5YN/A
EBIT Next Year159.57%
EBIT Next 3Y41.91%
EBIT Next 5Y29.78%
FCF growth 1Y227.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.28%
OCF growth 3YN/A
OCF growth 5YN/A

TERRASCEND CORP / TSND.CA FAQ

What is the fundamental rating for TSND stock?

ChartMill assigns a fundamental rating of 3 / 10 to TSND.CA.


Can you provide the valuation status for TERRASCEND CORP?

ChartMill assigns a valuation rating of 2 / 10 to TERRASCEND CORP (TSND.CA). This can be considered as Overvalued.


What is the profitability of TSND stock?

TERRASCEND CORP (TSND.CA) has a profitability rating of 3 / 10.


How financially healthy is TERRASCEND CORP?

The financial health rating of TERRASCEND CORP (TSND.CA) is 3 / 10.


What is the earnings growth outlook for TERRASCEND CORP?

The Earnings per Share (EPS) of TERRASCEND CORP (TSND.CA) is expected to grow by 24.44% in the next year.